University College London

University College London

University College London

Overview
Date Founded

1826

Headquarters

Gower Street,London, Greater London WC1E 6BT

Charitable Causes

Higher Education & Universities
Film, Radio & Arts Media
Education Research & Support

Company Description

University College London (UCL) is a public research university in London, England, and the oldest and largest constituent college of the federal University of London. Founded in 1826 as London University, UCL was the first university institution established in London and the first in England to be entirely secular, to admit students regardless of their religion, and to admit women on equal terms with men. The philosopher Jeremy Bentham is commonly regarded as the spiritual father of UCL, as his radical ideas on education and society were the inspiration to its founders, although his direct involvement in its foundation was limited. UCL became one of the two founding colleges of the University of London in 1836. It has grown through mergers, including with the Institute of Neurology (in 1997), the Royal Free Hospital Medical School (in 1998), the Eastman Dental Institute (in 1999), the School of Slavonic and East European Studies (in 1999) and the School of Pharmacy (in 2012). UCL's main campus is located in the Bloomsbury area of central London, with a number of institutes and teaching hospitals located elsewhere in central London, and satellite campuses in Adelaide, Australia and Doha, Qatar. UCL is organised into 10 constituent faculties, within which there are over 100 departments, institutes and research centres. UCL has around 26,700 students and 11,025 staff and had a total income of £937 million in 2012/13, of which £335 million was from research grants and contracts. UCL has around 4,000 academic and research staff and 650 full professors, the highest number of any British university. UCL is responsible for several museums and collections in a wide range of fields across the arts and sciences, including the Petrie Museum of Egyptian Archaeology, a leading collection of Egyptian and Sudanese archaeology.

Executives & Employees

Chief Operating Officer

President & Provost

President & Provost

Editor-in-Chief of Future Internet Journal

Vice Provost, Education & Student Affairs

Vice Provost, Enterprise & London

Vice Provost, Research

Dean, School of Health Sciences

Dean of Students, Academic

Dean, Faculty of Engineering

Board of Directors

Founder at iQur Ltd.

Distinguished Alumni
Lee Olesky is now Director & Chief Executive Officer at Tradeweb Markets, Inc.
Filippo John Cardini is now Chief Operating Officer, Managing Director at TowerBrook Capital Partners LP
Paths to University College London
Potential Connections via
Relationship Science
You
University College London
Recent Transactions
Details Hidden

inviCRO LLC purchases Imanova Ltd. from Medical Research Council, Imperial College London, University College London, King's College London

Details Hidden

University College London purchases Institute of Education

Advisors & Consultants
Scientific Advisor

Fellow at Trinity College - Cambridge

Legal Advisor

Managing Partner at Town Legal

Consultant

Consultant at Kim Donahue Consulting

Clients

MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1 and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.

Fortress Biotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The company was founded on June 28, 2006 and is headquartered in New York, NY.

Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom.

Non-Profit Donations & Grants Received
$150K
12/31/2017
$70K
12/31/2017
Investments
Details Hidden

ProAxon Ltd. develops sodium channel blockers that have a protective effect on neuronal cells and tissues. Its neuroprotective compounds help treatment of neurodegeneration diseases, pain and convulsions. The company was founded in 2003 by John Garthwaite, David Lawrence Selwood and Giti Garthwaite and is headquartered in London, the United Kingdom.

Details Hidden

Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom.

Details Hidden

MishiPay Ltd. develops payment processing solutions. Its platform allows shoppers to pick up a product they wish to buy, scan the barcode with their phone, and pay within the phone. The company was founded by Mustafa Khanwala and Tanvi Bhardwaj in August 2015 and is headquartered in London, the United Kingdom.

Suppliers
ISG plc Engineering, Construction & Architecture | London, United Kingdom

ISG Plc provides construction, fitting out and refurbishment services. Its service lines include: Fit out, Technology, Construction & Development. The firm’s portfolio of projects include: the construction and upgrade of data centers, laboratories, clean rooms and processing facilities as well as the renewal of critical infrastructure, such as boilers and chillers. It also engages in the delivering sustainable initiatives including solar devices and other energy-efficient solutions. The firm provides independent commissioning management and associated services to all industries reliant on mechanical and electrical building services systems for business operations. The company was founded in 1989 and is headquartered in London, the United Kingdom.

Abzena Ltd. Biotechnology | Cambridge, United Kingdom

Abzena Ltd. engages in the provision of proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It offers antibody discover and candidate screening, immunology and immunogenicity assessment, antibody and protein engineering, bio conjugation, custom synthesis of cytotoxic payloads, reagents, and other small molecules, manufacture of payload linkers, development of manufacturing cell lines, and manufacture of pharmaceuticals. The company was founded by Sunil Shaunak in 2001 and is headquartered in Cambridge, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by University College London. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of University College London's profile does not indicate a business or promotional relationship of any kind between RelSci and University College London.